<div id="readability-page-1">We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Guardant Health, Inc. is one of the most promising stocks. TheFly reported on December 17 that Mizuho analyst Anthony Petrone maintained an Outperform rating on GH and raised the price target to $120 from $100, reflecting growing confidence in […]</div>

<p>我們最近整理了一份分析師認為的 7 只最具潛力的基因編輯股票名單。Guardant Health, Inc. 是其中最具潛力的股票之一。《TheFly》在 12 月 17 日報道稱，瑞穗證券分析師 Anthony Petrone 維持了對 GH 的 “跑贏大盤” 評級，並將目標價從 100 美元上調至 120 美元，反映出對……的信心不斷增強</p>

多位分析師因篩查和數據增長上調了 Guardant Health, Inc.（GH）的目標價